Login / Signup

Recurrence Risk Evaluation in Patients with Papillary Thyroid Carcinoma: Multicenter Machine Learning Evaluation of Lymph Node Variables.

Sung-Woo JangJae Hyun ParkHae-Rim KimHyeong-Ju KwonYu Mi LeeSuck-Joon HongJong Ho Yoon
Published in: Cancers (2023)
In PTC patients with an N1 classification, our novel LN-related risk estimates may help predict long-term outcomes and design postoperative management and follow-up strategies. After further validation studies based on independent datasets, these risk categories might be considered when redefining risk stratification or staging systems.
Keyphrases
  • lymph node
  • machine learning
  • deep learning
  • clinical trial
  • neoadjuvant chemotherapy
  • radiation therapy
  • artificial intelligence
  • cross sectional
  • double blind